The March 2026 FOCM | GLSA Virtual Networking Event Recap
Event Date: March 18, 2026
The March 2026 GLSA / FOCM Virtual Networking Event brought together a dynamic group of life sciences leaders, innovators, and problem-solvers for an engaging session focused on connection, collaboration, and forward-thinking strategy.
From industry challenges to the evolving role of AI in clinical trials, this session captured exactly what makes the GLSA Network so powerful: real conversations that lead to real solutions.
Building Connections That Matter
As with every GLSA networking event, the session began with informal conversation and relationship-building. Whether attendees were reconnecting with familiar faces or meeting new collaborators, the importance of authentic connection in a fast-moving industry was clear.
These moments, often overlooked in traditional conferences, are where partnerships begin. And in an industry as complex as life sciences, those relationships are everything.
Industry Challenges: Monitoring & Auditing in Oncology Trials
One of the most impactful discussions centered around a growing challenge in clinical research:
Limited monitoring and audit access at large oncology sites.
Participants shared real-world experiences navigating institutional barriers, with key insights including:
- The importance of engaging local IRBs (Institutional Review Boards) when access is restricted
- Escalating issues through regulatory pathways when compliance is at risk
- The potential need to pause or stop enrollment at non-compliant sites
This wasn’t just a discussion, it was a working session. Action items included connecting experts within the GLSA Network to help address these barriers and ensure clinical trial integrity.
Spotlight on Innovation: AI in Clinical Trials
A highlight of the session was an engaging discussion led by GLSA Network Partner, Jax Manwaring of Adaptr AI, who challenged attendees to rethink how they approach artificial intelligence.
The key takeaway?
AI is not just a tool, it’s a thought partner.
Jax emphasized that many leaders struggle with AI adoption not because of the technology itself, but because they lack a personal relationship with it. Without hands-on experience, it becomes difficult to delegate, implement, or fully leverage its capabilities.
Practical Ways AI Is Transforming Workflows
Attendees explored how tools like ChatGPT and Claude are already making an impact across organizations:
- Streamlining administrative tasks
- Enhancing strategic planning and decision-making
- Reviewing transcripts and identifying blind spots
- Supporting design, analysis, and communication workflows
One particularly powerful idea shared:
Using AI to challenge your thinking, uncover gaps, and improve outputs and not just execute tasks.
A 90-Day Challenge for Leaders
Jax left the group with a compelling call to action:
Spend 90 days actively engaging with AI.
By doing so, leaders can:
- Better understand its strengths and limitations
- Build confidence in delegating AI-driven work
- Empower their teams to integrate AI more effectively
This mindset shift, moving from observer to active user.
GLSA Updates: GLSA Site Nexus & Network Growth
The session also included updates on the continued expansion of the GLSA ecosystem, including the launch of GLSA Site Nexus, a platform designed to better connect sites, sponsors, and service providers across the network.
With new partners joining and increased collaboration opportunities, GLSA continues to strengthen its mission:
to accelerate innovation by connecting the right people at the right time.
What Makes GLSA Networking Different
Led by Chris Matheus, the GLSA / FOCM Networking Event is not just another virtual meeting. It is:
- A space for open dialogue and real problem-solving
- A platform for meaningful, curated introductions
- A community driven by collaboration over competition
Each session is intentionally designed to deliver value, whether through insights, connections, or actionable next steps.
Looking Ahead
As the life sciences industry continues to evolve, one thing is clear:
The future belongs to those who collaborate, adapt, and embrace innovation.
From tackling operational challenges to redefining how we work with AI, the March 2026 session was a powerful reminder that progress happens when the right minds convene.
If you missed this session, be sure to join us for the next GLSA Accelerated Partnering and Networking Event. The conversations you need, and the connections that can move your business forward, are happening here.
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.
Subscribe to receive GLSA Event Notifications here: GLSA Event Notifications
Subscribe to receive GLSA Accelerated Partnering here: GLSA Accelerated Partnering